Morgan Stanley »

Sagimet Biosciences Inc-a shares owned by Morgan Stanley

Quarter-by-quarter ownership of Sagimet Biosciences Inc-a (SGMT) shares owned by Morgan Stanley from 13F filings

Historical chart of Morgan Stanley investment in Sagimet Biosciences Inc-a

Tip: Access up to 7 years of quarterly data

All positions including Sagimet Biosciences Inc-a held by Morgan Stanley consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Sagimet Biosciences Inc-a by Morgan Stanley

Quarter filed Position value Share count Share price at filing
2024-03-31 $440k 81k 5.42
2023-09-30 $154k 18k 8.80

More positions owned by Morgan Stanley

Microsoft Corporation (MSFT)
Apple (AAPL)
NVIDIA Corporation (NVDA)
Amazon (AMZN)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Alphabet Cap Stk Cl A (GOOGL)
Meta Platforms Cl A (META)
Visa Com Cl A (V)
JPMorgan Chase & Co. (JPM)
Alphabet Cap Stk Cl C (GOOG)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Eli Lilly & Co. (LLY)
Ishares Tr Core S&p500 Etf (IVV)
UnitedHealth (UNH)

View all positions for Morgan Stanley

Top funds holding Sagimet Biosciences Inc-a

Point72 Asset Management
BlackRock
NEA Management Company
Blue Owl Capital Holdings
Baker Bros. Advisors
Vanguard Group
Jpmorgan Chase & Co
Alyeska Investment Group
Rtw Investments
Partner Fund Management
Rock Springs Capital Management
Hillhouse Capital Advisors
Artal Group
Millennium Management
Renaissance Technologies

View all funds holding Sagimet Biosciences Inc-a